ArticleJournal for immunotherapy of cancer2018

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer.

Randy F Sweis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.